198 related articles for article (PubMed ID: 16412252)
1. Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers.
Hebert C; Norris K; Parashar P; Ord RA; Nikitakis NG; Sauk JJ
Mol Cancer; 2006 Jan; 5():3. PubMed ID: 16412252
[TBL] [Abstract][Full Text] [Related]
2. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
Sasabe E; Yang Z; Ohno S; Yamamoto T
Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
[TBL] [Abstract][Full Text] [Related]
6. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
8. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract][Full Text] [Related]
9. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
[TBL] [Abstract][Full Text] [Related]
10. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Kumar SM; Yu H; Edwards R; Chen L; Kazianis S; Brafford P; Acs G; Herlyn M; Xu X
Cancer Res; 2007 Apr; 67(7):3177-84. PubMed ID: 17409425
[TBL] [Abstract][Full Text] [Related]
11. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
Fu XS; Choi E; Bubley GJ; Balk SP
Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
[TBL] [Abstract][Full Text] [Related]
12. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma.
Chang CC; Lin BR; Chen ST; Hsieh TH; Li YJ; Kuo MY
J Oral Pathol Med; 2011 Aug; 40(7):567-75. PubMed ID: 21332579
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
Brugarolas J; Lei K; Hurley RL; Manning BD; Reiling JH; Hafen E; Witters LA; Ellisen LW; Kaelin WG
Genes Dev; 2004 Dec; 18(23):2893-904. PubMed ID: 15545625
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
Land SC; Tee AR
J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
[TBL] [Abstract][Full Text] [Related]
18. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
[TBL] [Abstract][Full Text] [Related]
19. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.
Putra AC; Tanimoto K; Arifin M; Hiyama K
Respirology; 2011 Jul; 16(5):796-802. PubMed ID: 21435097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
